← Eichor
Study identifier: NCT06841731 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Condition: Hospital-acquired Bacterial Pneumonia (HABP) · Ventilator-associated Bacterial Pneumonia (VABP)  ·  Sponsor: Jiangsu HengRui Medicine Co., Ltd.

PhasePhase 2
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaopeng Wang  ·  +86-0518-81220121  ·  xiaopeng.wang@hengrui.com

Yaru Wei  ·  +86-010-67166319  ·  yaru.wei.yw37@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (1)

China-Japan Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06841731